BENDAMUSTINE HCloncology product with a “low side effects” profile
FROM A RELIABLE SOURCE
THERAPEUTIC INDICATION: ONCOLOGY
For the treatment of chronic lymphocytic leukemia and lymphomas.
Originator product: RIBOMUSTIN®
Core patent exclusivities: Patents expired
- Oncology product with a “low side effects” profile
- Good quality API with reliable supply
This article uses material from Wikipedia, which is released under the Creative Commons Attribution-Share-Alike License 3.0.